previous
isol
sever
igg
rheumatoid
factor
rf
patient
rheumatoid
arthriti
idiopath
thrombocytopenia
purpura
use
phage
display
system
studi
igg
rf
patient
autoimmun
diseas
phage
display
antibodi
librari
hepat
c
viru
infect
patient
syndrom
construct
pan
specif
clone
isol
character
advanc
bind
activ
specif
igg
fc
fragment
compar
rf
previous
isol
analysi
exist
rffc
complex
structur
indic
homolog
model
similar
igm
complex
high
bind
affin
effect
result
longer
complementaritydetermin
region
cdr
combin
key
somat
mutat
interfac
loop
form
fingerlik
structur
extend
bottom
fc
pocket
result
strong
ion
cationpi
interact
moreov
process
antigendriven
matur
proven
somat
mutat
vh
residu
cdr
loop
interfac
taken
togeth
result
suggest
high
affin
igg
rf
gener
patient
syndrom
may
play
import
role
pathogenesi
autoimmun
diseas
syndrom
ss
autoimmun
disord
mainli
affect
exocrin
gland
usual
present
persist
dryness
mouth
eye
due
function
impair
salivari
lachrym
gland
ss
occur
primari
form
associ
diseas
secondari
form
complic
rheumat
condit
common
rheumatoid
arthriti
posit
rf
found
patient
main
extraglandular
ss
hand
circul
monoclon
immunoglobulin
igm
kappa
igg
lambda
detect
signific
higher
frequenc
sshcv
patient
compar
primari
ss
patient
scientif
world
journal
hepat
c
viru
hcv
demonstr
one
like
candid
potenti
pathogen
agent
caus
ss
subset
patient
mani
rheumatolog
manifest
associ
chronic
hcv
infect
includ
arthralgia
myalgia
arthriti
vascul
sicca
syndrom
clinic
studi
suggest
possibl
close
relationship
among
ss
hcv
bcell
lymphoprolif
disord
tripl
associ
suggest
import
role
associ
autoimmun
andor
chronic
viral
diseas
pathogenesi
bcell
lymphoprolif
disord
reinforc
hypothesi
link
among
autoimmun
infect
cancer
rheumatoid
factor
rf
antibodi
direct
fc
part
autolog
igg
characterist
marker
rheumatoid
arthriti
ra
chronic
joint
inflamm
unknown
etiopathogenesi
complex
format
rf
igg
may
lead
activ
complement
inflammatori
mediat
directli
physiolog
rf
mainli
belong
igm
isotyp
serv
benefici
role
host
defens
facilit
clearanc
antigen
enhanc
complement
activ
phagocytosi
opposit
patholog
rf
associ
ra
system
autoimmun
diseas
monospecif
igg
rf
implic
caus
inflamm
tissu
damag
rheumatoid
synovium
corper
et
al
first
group
visual
rf
bind
crystal
structur
directli
show
epitop
span
junction
c
c
domain
fc
fragment
anoth
studi
duquerroy
et
al
determin
differ
epitop
recognit
site
use
igm
rf
definit
c
interfac
includ
ctermin
region
heavi
chain
distant
previous
identifi
c
interfac
complex
gener
igm
rf
origin
indic
involv
somat
mutat
interact
interfac
human
monoclon
antibodi
great
demand
therapeut
diagnost
purpos
combinatori
methodolog
improv
rapidli
dramat
particularli
express
combinatori
antibodi
fab
fragment
phage
surfac
allow
rapid
enrich
desir
fab
fragment
target
antigen
techniqu
use
studi
pathogen
autoantibodi
variou
human
autoimmun
disord
studi
igg
rf
syndrom
patient
hcv
infect
use
combinatori
antibodi
techniqu
character
isol
rf
fab
molecul
result
allow
us
defin
pathogen
role
rf
play
autoimmun
diseas
complic
viral
infect
addit
insight
genet
level
clue
expect
reveal
associ
caus
autoimmun
disord
order
comprehens
explain
interact
antibodi
target
antigen
molecular
model
employ
power
reliabl
approach
ration
model
predict
antibodyantigen
complex
analyz
compar
xray
crystal
structur
antibodyantigen
complex
retriev
protein
data
bank
pdb
mani
research
demonstr
suffici
inform
avail
analysi
indic
critic
residu
great
influenc
bind
site
antibodyantigen
recognit
interfac
studi
demonstr
isol
igg
rf
better
bind
affin
exist
complex
gener
igm
rf
molecul
manag
construct
antibodi
model
via
homolog
model
use
structur
align
loop
minim
illustr
possibl
role
somat
mutat
induc
cdr
area
interact
logic
reason
predict
result
provid
probabl
explan
insight
divers
origin
igg
rf
antibodi
librari
two
antibodi
librari
construct
express
antibodi
bind
fragment
fab
patient
syndrom
associ
hepat
c
infect
librari
size
light
chain
respect
equal
amount
phage
particl
taken
two
librari
mix
evenli
subsequ
pan
cycl
antigenbind
clone
prepar
librari
enrich
pan
antigenco
surfac
elisa
plate
costar
report
previous
briefli
human
fc
fragment
protein
sigma
coat
target
protein
ugwel
c
overnight
block
skim
milk
pfu
recombin
phage
ad
well
incub
c
hr
unbound
phage
remov
well
wash
vigor
trisbuff
salin
contain
tbst
ten
time
next
bound
phage
elut
hclglycin
ph
neutral
trisbas
elut
phage
use
infect
e
coli
strain
grow
log
phase
phagemid
particl
rescu
infect
e
coli
cell
pfu
helper
phage
stratagen
cultur
amplif
nacl
use
precipit
recombin
phage
particl
final
phage
resuspend
pb
use
next
round
pan
pan
process
human
fc
fragment
repeat
four
time
thereaft
total
phagemid
dna
prepar
digest
nhe
spe
neb
biolab
remov
phage
protein
iii
gene
digest
dna
compat
cohes
end
selflig
electropor
e
coli
cell
individu
clone
grown
overnight
presenc
mm
isopropyl
bdthiogalactopyranosid
iptg
fab
protein
induct
supernat
contain
express
fab
molecul
harvest
elisa
western
blot
assay
briefli
microtit
plate
coat
ugwel
human
fc
fragment
protein
c
overnight
well
block
skim
milk
hr
room
temperatur
express
fab
molecul
prepar
describ
distribut
well
duplic
incub
hr
room
temperatur
wash
pb
contain
pbst
six
time
well
react
scientif
world
journal
horseradishperoxidas
hrp
conjug
goat
antihuman
light
chain
antibodi
jackson
immunoresearch
laboratori
hr
room
temperatur
well
wash
pbst
six
time
dihydrochlorid
tmb
substrat
ad
color
develop
reaction
stop
addit
n
hcl
absorb
taken
nm
character
bind
specif
select
fcbind
fab
studi
reactiv
type
vi
collagen
sigma
lipopolysaccharid
lp
sigma
keyhol
limpet
haemocyanin
klh
sigma
thyroglobulin
sigma
calf
thymu
singlestrand
dna
ssdna
sigma
simultan
elisa
analysi
carri
describ
amount
antigen
use
coat
ugwel
examin
fab
express
iptginduc
bacteri
lysat
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
onto
nitrocellulos
membran
ge
bioscienc
uk
follow
block
skim
milk
pbst
hr
room
temperatur
gentli
shake
wash
hrpconjug
goat
antihuman
light
chain
antibodi
ad
incub
one
addit
hour
room
temperatur
gentli
shake
wash
pbst
membran
develop
diaminobenzidin
dab
substrat
desir
intens
reach
examin
bind
abil
cellular
lysat
contain
recombin
fab
molecul
sera
hcvinfect
patient
syndrom
incub
human
fc
fragment
fix
western
blot
human
fc
fragment
transfer
onto
nitrocellulos
membran
experi
perform
describ
competit
inhibit
assay
carri
determin
bind
affin
fcbind
fab
molecul
brief
microtitr
plate
coat
human
fc
fragment
gwell
block
skim
milk
one
hour
incub
room
temperatur
plate
wash
pbst
twice
purifi
fab
incub
first
variou
concentr
solubl
fc
fragment
dilut
pb
rang
gml
room
temperatur
hr
mixtur
ad
well
react
coat
human
fc
fragment
incub
room
temperatur
hr
plate
wash
pbst
six
time
thereaft
hrpconjug
goat
antihuman
light
chain
antibodi
jackson
immunoresearch
laboratori
incub
room
temperatur
hr
detect
bound
fab
protein
wash
pbst
six
time
tmb
substrat
sigma
ad
well
develop
reaction
stop
n
hcl
signal
intens
measur
od
nm
dna
sequenc
analysi
light
heavi
chain
insert
fcbind
clone
sequenc
analyz
primer
complementari
constant
region
heavi
chain
seqgb
gtc
gtt
gac
cag
gca
gcc
mer
lambda
light
chain
seqlb
gaa
gtc
act
tat
gag
aca
mer
use
imgtvquest
intern
immunogenet
inform
system
http
wwwimgtorg
use
compil
analyz
sequenc
data
parallel
germlin
gene
model
antihuman
igg
fc
fab
found
possess
highest
affin
among
sever
clone
screen
studi
model
scfv
scaffold
use
homolog
model
program
obtain
reliabl
light
chain
model
sequenc
align
light
chain
antibodi
pdb
id
use
show
homolog
exclus
inclus
cdr
respect
similarli
build
heavi
chain
model
heavi
chain
sequenc
show
high
similar
compar
anoth
antibodi
pdb
id
exclus
inclus
cdr
homolog
model
gener
model
program
discoveri
studio
accelri
softwar
inc
san
diego
ca
usa
use
crystallograph
structur
light
chain
pdb
id
heavi
chain
antibodi
pdb
id
structur
templat
structur
good
resolut
belong
homo
sapien
thu
interfac
templat
structur
l
chain
h
chain
employ
build
light
chainheavi
chain
interfac
scfv
model
owe
light
chain
antibodi
high
homolog
cdr
may
bind
similar
epitop
igg
fc
see
tabl
complex
structur
model
interact
igg
fc
antigen
built
align
complex
structur
fc
obtain
fc
complex
instead
use
dock
method
avoid
uncertain
orient
interact
two
protein
cdr
interact
igg
fc
antigen
energi
minim
use
dreidinglik
forc
field
discoveri
studio
step
remov
inappropri
contact
obtain
reliabl
complex
structur
two
fabdisplay
phage
librari
construct
hepat
c
viru
infect
patient
syndrom
number
heavi
chain
combin
either
light
chain
respect
evalu
ratio
clone
lack
correct
insert
librari
amplif
fifti
clone
librari
select
restrict
analysi
confirm
presenc
bp
fragment
contain
heavi
light
chain
gene
result
reveal
clone
select
two
librari
correct
gene
insert
data
shown
fcbind
phage
enrich
four
round
pan
input
phage
number
appli
pan
process
gener
seen
elut
phage
titer
final
round
one
order
higher
first
pan
figur
pan
scientif
world
journal
abbrevi
denot
side
chain
main
chain
respect
denot
residu
somat
mutat
clone
randomli
select
check
presenc
dna
insert
correct
length
result
show
clone
contain
fragment
bp
plasmid
dna
second
around
pan
data
shown
indic
pan
elimin
phage
clone
display
fab
fragment
surfac
account
less
phage
clone
origin
antibodi
librari
construct
thereaft
gene
iii
fragment
remov
phagemid
dna
purifi
e
coli
cultur
pan
express
iptginduc
fab
antibodi
nonreduc
condit
clearli
detect
shown
figur
b
except
one
clone
incomplet
nucleotid
sequenc
immunoglobulin
isotyp
anaysi
indic
rf
molecul
contain
light
chain
find
antibodi
light
chain
human
fc
clone
contain
light
chain
fab
test
bind
activ
specif
clone
high
bind
specif
fc
lpsl
clone
antilp
antiredblood
surfac
ag
appli
posit
neg
control
respect
select
fab
fragment
show
signific
bind
activ
fc
bsa
figur
c
moreov
recognit
human
fc
fragment
immobil
western
blot
test
result
show
serum
hcvinfect
patient
ss
diseas
figur
b
recombin
fab
molecul
repres
figur
c
could
clearli
recogn
fc
protein
fcbind
activ
observ
irrever
fab
molecul
appli
figur
order
test
bind
specif
unrel
antigen
includ
collagen
klh
lp
calf
thymu
ssdna
thyroglobulin
use
elisa
test
shown
figur
repres
fab
antibodi
well
posit
clone
show
specif
bind
activ
fc
fragment
minim
bind
panel
unrel
antigen
bind
specif
affin
determin
competit
inhibit
assay
demonstr
figur
inhibitori
effect
found
bind
reactiv
fab
coat
human
fc
fragment
presenc
concentr
ugml
free
fc
fragment
perform
parallel
close
inhibitori
effect
seen
use
posit
fab
antibodi
none
detect
use
neg
fab
molecul
valu
antibodi
calcul
use
klotz
plot
method
nucleotid
sequenc
vh
vl
region
fcbind
clone
determin
compar
potenti
germlin
light
chain
heavi
chain
determin
shown
highest
homolog
tabl
three
nucleotid
differ
identifi
region
light
chain
gene
two
chang
nucleotid
posit
gat
cag
result
amino
acid
residu
chang
aspart
glutamin
q
third
chang
nucleotid
agc
aac
led
amino
acid
residu
chang
serin
asparagin
n
figur
similarli
two
nucleotid
chang
heavi
chain
mutat
tyrosin
phenylalanin
f
lysin
k
asparagin
n
respect
compar
germlin
gene
four
continu
residu
somat
mutat
make
nyyi
ttdf
region
figur
b
compar
sequenc
cdr
domain
rf
molecul
light
chain
show
similar
except
replac
aspart
serin
glutamin
q
asparagin
n
heavi
chain
signific
dissimilar
cdr
shown
addit
residu
besid
framework
high
similar
figur
igg
fc
antigen
investig
interact
igg
fc
six
cdr
make
contact
except
loop
loop
domin
interact
fc
shown
figur
interact
loop
igg
fc
found
side
chain
side
chain
loop
correspondingli
act
igg
fc
respect
interact
involv
anionpi
interact
cationpi
interact
respect
addit
two
interact
hbond
also
involv
exemplifi
side
chain
act
side
chain
via
two
hbond
side
chain
interact
main
chain
produc
hbond
moreov
hbond
also
produc
side
chain
side
chain
loop
form
fingerlik
structur
extend
bottom
deep
pocket
igg
fc
compos
l
h
four
differ
interact
gener
loop
fc
name
ion
interact
cationpi
interact
hbond
hydrophob
interact
igg
fcbind
surfac
contain
main
charg
residu
involv
ion
interact
cationpi
interact
loop
figur
moreov
side
chain
loop
interact
hl
chain
c
domain
via
two
hydrophob
contact
side
chain
side
chain
loop
respect
interact
igg
fc
result
format
hbond
studi
describ
isol
character
fab
direct
human
igg
fc
patient
syndrom
hcv
infect
differ
physiolog
rf
aris
normal
antibodi
respons
aid
exogen
antigen
clearanc
rf
may
involv
pathogenesi
patient
sshcv
infect
isol
igg
rf
proven
bind
specif
human
igg
fc
fragment
bind
affin
determin
competit
inhibit
assay
figur
sequenc
put
germlin
counterpart
includ
comparison
sequenc
gap
introduc
maxim
align
indic
blank
space
boundari
framework
region
fr
complementaritydetermin
region
cdr
indic
germlin
gene
sequenc
serum
sampl
patient
syndrom
reveal
presenc
igg
rf
figur
although
phagederiv
fab
may
repres
artefact
recombin
h
l
chain
librari
construct
characterist
isol
could
still
hint
verifi
exist
high
affin
rf
patient
syndrom
data
suggest
igg
type
rf
may
occur
patient
syndrom
igg
type
rf
may
bind
affin
higher
igm
igg
rf
isol
autoimmun
diseas
studi
character
pathogen
rf
import
comprehend
interact
rf
fc
well
realiz
influenc
somat
mutat
antibodi
gene
comparison
heavi
chain
light
chain
variabl
gene
sequenc
germlin
counterpart
identifi
ten
probabl
somat
mutat
two
framework
vl
vh
eight
cdr
figur
unlik
antibodi
gene
variat
isol
previou
work
substanti
amount
somat
mutat
occur
cdr
even
framework
region
order
fight
exogen
pathogen
pathogen
rf
caus
immun
system
disord
howev
possess
sequenc
similar
endogen
germlin
sequenc
genet
level
except
critic
mutat
occur
cdr
provid
bindingspecif
abil
igg
fc
domain
impli
gener
rf
autoimmun
antibodi
attain
critic
chang
convert
physiolog
rf
pathogen
rf
gener
output
phage
valu
enrich
impli
success
pan
process
greater
lower
enrich
level
nonspecif
low
affin
scientif
world
journal
cdr
color
scfvfc
complex
model
figur
interfac
structur
focus
color
blue
color
magenta
loop
panel
human
igg
fc
antigen
color
cyan
color
six
cdr
figur
format
residu
fc
antigen
loop
abbrevi
three
word
residu
code
distinguish
antigen
antibodi
respect
green
red
dot
line
panel
repres
hbond
anionc
interact
fc
respect
panel
green
red
yellow
dot
line
show
hbond
cationpi
hydrophob
interact
respect
binder
could
caus
outgrowth
output
phage
amplif
moreov
pan
process
although
elut
phage
titer
mild
increas
rais
one
order
magnitud
final
round
pan
still
enrich
isol
specif
phage
binder
origin
librari
success
figur
interest
show
output
phage
number
pan
process
instant
increment
third
cycl
although
drop
slightli
second
round
figur
result
agre
studi
sequenc
isol
clone
follow
final
pan
almost
clone
identifi
similar
anoth
verif
convinc
effici
pan
process
result
high
affin
clone
becom
domin
final
librari
pool
result
competit
inhibit
assay
high
bind
affin
fab
antihuman
igg
fc
capabl
confirm
share
high
similar
l
chain
amino
acid
sequenc
autoantibodi
report
differ
anoth
autoantibodi
pdb
id
lower
bind
affin
alreadi
publish
addit
cdr
h
chain
two
three
amino
acid
respect
amino
acid
sequenc
framework
highli
similar
despit
fact
come
differ
immunoglobulin
isotyp
igg
igm
type
resp
antigen
igg
fc
accordingli
reason
infer
epitop
recogn
high
similar
dock
simul
antibodi
igg
fc
antigen
use
zdock
program
also
reveal
epitop
highli
similar
correspond
order
establish
reliabl
structur
model
antibodyfc
complex
use
structur
align
cdr
loop
minim
replac
dock
approach
domin
interact
loop
igg
fc
clearli
observ
investig
demonstr
superior
bind
affin
indic
experi
tabl
illustr
epitop
residu
igg
fc
fc
individu
form
hbond
cationpi
interact
loop
infer
key
residu
igg
fc
epitop
howev
paratop
loop
loop
gener
somat
mutat
respect
form
hbond
anionpi
interact
respect
indic
import
somat
mutat
loop
compar
loop
two
addit
amino
acid
loop
interact
fc
strong
hbond
show
loop
bind
affin
stronger
loop
igg
fc
loop
three
amino
acid
loop
three
amino
acid
belong
four
amino
acid
produc
somat
mutat
hbond
hydrophob
ion
interact
form
igg
fc
four
amino
acid
among
form
critic
strong
ion
interact
igg
fc
moreov
also
contribut
format
cationpi
interact
shown
tabl
ion
interact
form
igg
fc
via
thu
key
residu
igg
fc
epitop
base
comparison
made
accord
tabl
infer
loop
bind
affin
igg
fc
similar
loop
might
differ
fc
epitop
also
structur
model
observ
loop
form
fingerlik
structur
extend
bottom
deep
pocket
igg
fc
differ
ellipselik
structur
bound
igg
fc
form
due
fingerlik
structur
loop
interact
dimer
togeth
form
interact
igg
fc
see
figur
provid
bind
affin
loop
higher
loop
bind
structur
fc
although
novel
epitop
found
confirm
igg
type
rf
differ
igm
type
rf
discov
differ
cdr
loop
particularli
substanti
differ
paratop
studi
show
stronger
bind
affin
somat
mutat
comput
structur
biolog
investig
line
experi
studi
illustr
high
specif
high
bind
affin
rf
may
possibl
exist
ss
patienc
analyz
isol
rf
sequenc
manag
explain
reason
isol
may
possess
high
affin
igg
fc
structur
simul
perspect
although
direct
relationship
isol
rf
autoimmun
diseas
establish
demonstr
meaning
rf
chang
paratop
cdr
somat
mutat
induc
pathogen
high
bind
affin
provid
insight
inform
guidanc
use
futur
rf
research
